ETF Objective

The Fund seeks daily investment results, before fees and expenses, of 300% of the performance of the S&P 500 Index. The Fund seeks daily leveraged investment results and does not seek to achieve its stated investment objective over a period of time greater than one day.

Stock Chart

as of 4:10 PM ET 09/20/2021


  • 1 Week
  • -7.48%
  • 1 Month
  • -5.70%
  • 3 Months
  • +14.06%
  • 1 Yr Return
  • +117.54%
  • 5 Yr Return
  • +374.30%

Sector Breakdown

Technology 21.40%
Financials 11.30%
Consumer Services 9.85%
Health Care 8.62%
Industrials 8.46%
Consumer Goods 5.93%
Oil & Gas 1.88%
Utilities 1.79%
Basic Materials 1.41%
Telecommunications 1.02%

Geographic Exposure

United States 90.36%
Unidentified 28.83%
Ireland 1.36%
United Kingdom 0.55%
Switzerland 0.29%
Netherlands 0.11%
Bermuda 0.02%

Top 10 Holdings

No Top 10 Holdings Information

ETF Overview

Sponsor Direxion
iNav Ticker FNVM
Inception Date 11/05/2008
Name Direxion:S&P 500 Bull 3X
CUSIP 25459W862
Prospectus Date 02/28/2021

ETF Characteristics

Market Capitalization 391.72 B
Total Net Assets 2.85 K
Management Fee 0.77%
Administration Fee 0.03%
Asset Class Equity
Sub Asset Class Equity Leverage Funds
Number Of Holdings 8
Expense Ratio 0.95
Dividend 0.04
Dividend Frequency Annually


Recent Articles from TheStreet

Uber Lead

Premarket Movers Tuesday: Uber, Johnson & Johnson, Apple

Stocks moving in premarket trading Tuesday include Uber, Johnson & Johnson, U.S. Bancorp, Lennar and Apple.


How China’s Focus on Low Emissions Could Affect Industrial Metals

China has set a target for non-fossil fuel sources to account for 20% of the country’s energy by 2025. That could accelerate copper demand.

Watch: Jim Cramer Says Lennar Is a Buy

Lennar Stock Slides After Q3 Earnings Miss, Supply Chain Impact On Homebuilders

"Lennar, as well as the U.S. housing market, "continued to experience unprecedented supply chain challenges which we believe will continue into the foreseeable future," said chairman Stuart Miller.

Johnson & Johnson Lead

Johnson & Johnson Says Second COVID Vaccine Dose Boosts Overall Efficacy To 94%

"Our large real-world evidence and Phase 3 studies confirm that the single-shot Johnson & Johnson vaccine provides strong and long-lasting protection against COVID-19-related hospitalizations," the drugmaker said.


Stocks Rebound As Evergrande Worries Fade With Fed Meeting Now In Focus

Wall Street looks set to rebound from its biggest single-day decline in four months Tuesday as investors shift focus from China Evergrande's failure to the Fed's two-day policy meeting.

Wall Street NYSE Lead

Stocks Rebound, Evergrande Defiant, Universal Music Soars on Debut - 5 Things You Must Know

Stock futures rebound from Monday sell-off; China Evergrande chairman vows to recover; Lennar ads name to list of cautious homebuilders; Trudeau wins historic third term and Universal Music Group sings loudly on Amsterdam debut.